Related Experiment Videos
Kawasaki disease and its cardiac sequelae
1Department of Pediatrics, Harvard Medical School.
Hospital Practice (Office Ed.)
|November 15, 1993
Summary
Kawasaki disease is a leading cause of acquired heart disease in children, primarily affecting toddlers. Early diagnosis and treatment with intravenous gamma globulin are crucial to reduce inflammation and prevent cardiac complications.
Area of Science:
- Pediatrics
- Cardiology
- Immunology
Background:
- Kawasaki disease, first described in 1967, is a significant cause of acquired heart disease in children.
- It predominantly affects children under five years old, with rare cases in adolescents.
Observation:
- The syndrome involves mucocutaneous inflammation and can lead to cardiac failure in 1-2% of affected children.
- Cases have been reported worldwide across all racial groups.
Findings:
- Intravenous gamma globulin (IVIG) has shown efficacy in reducing systemic inflammation and coronary artery aneurysms.
- Treatment effectiveness is highly dependent on early administration.
Implications:
- Prompt and accurate diagnosis of Kawasaki disease is essential for timely and effective treatment.
- Understanding the clinical issues surrounding Kawasaki disease is vital for pediatric healthcare providers.